Provided by Tiger Trade Technology Pte. Ltd.

Harvard Bioscience

7.48
-0.0700-0.93%
Volume:10.66K
Turnover:80.02K
Market Cap:34.05M
PE:-3.18
High:7.64
Open:7.64
Low:7.37
Close:7.55
52wk High:9.40
52wk Low:3.76
Shares:4.55M
Float Shares:3.55M
Volume Ratio:0.37
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3486
EPS(LYR):-12.8000
ROE:-89.95%
ROA:1.58%
PB:4.59
PE(LYR):-0.58

Loading ...

Harvard Bioscience Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 12

Harvard Bioscience reports Q4 adjusted EPS (0c) vs 6c last year

TIPRANKS
·
Mar 12

Harvard Bioscience appoints interim CFO Mark Frost as CFO

TIPRANKS
·
Mar 12

Harvard Bioscience sees Q1 revenue $20M-$22M

TIPRANKS
·
Mar 12

Harvard Bioscience sees FY26 revenue growth 2%-4%

TIPRANKS
·
Mar 12

Harvard Bioscience Q4 2025 net loss was USD 2.8 million as revenue fell 5% to USD 23.7 million

Reuters
·
Mar 12

Harvard Bioscience Q4 Sales $23.735M Beat $23.100M Estimate

Benzinga Earnings
·
Mar 12

Harvard Bioscience Outlook FY Gross Margin 58-60%

THOMSON REUTERS
·
Mar 12

Harvard Bioscience: FY2026 Growth Expected to Be Supported by Stabilized Nih Funding Environment, Reduction in Tariff Disruptions

THOMSON REUTERS
·
Mar 12

Harvard Bioscience - for Q1 2026, Co Expects Revenue Between $20.0 Mln and $22.0 Mln

THOMSON REUTERS
·
Mar 12

Harvard Bioscience Inc FY2026 REV View $92.6 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Mar 12

Harvard Bioscience Inc - Interim CFO Mark Frost Appointed CFO on Permanent Basis

THOMSON REUTERS
·
Mar 12

Harvard Bioscience Q4 Revenue USD 23.735 Million

THOMSON REUTERS
·
Mar 12

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

GlobeNewswire
·
Mar 12

Harvard Bioscience Inc expected to post earnings of 4 cents a share - Earnings Preview

Reuters
·
Mar 10

Harvard Bioscience Updates Executive Contracts and Finance Leadership

TIPRANKS
·
Mar 10

Harvard Bioscience appoints Mark Frost as CFO and treasurer

Reuters
·
Mar 10

Harvard Bioscience Inc - Appoints Mark Frost as Chief Financial Officer Effective March 6, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 10

Harvard Bioscience Inc - Board Approves 1-for-10 Reverse Stock Split of Common Stock

THOMSON REUTERS
·
Mar 07

Harvard Bioscience Announces Reverse Stock Split

GlobeNewswire
·
Mar 07